Mangalam Drugs VS Pharmaceuticals & Biotechnology 
1D
-1.14%
1.23%
1W
7.28%
0.78%
1M
-1.77%
-3.07%
YTD
12.76%
-14.96%
1Y
-54.78%
-11.8%
3Y
-68.72%
10.62%
5Y
-78.84%
20.67%
10Y
-81.42%
158.27%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.54%
0%
14.54%
6 Months
-0.22%
0%
-0.22%
1 Year
-54.78%
0%
-54.78%
2 Years
-74.56%
0%
-74.56%
3 Years
-68.72%
0%
-68.72%
4 Years
-78.41%
0%
-78.41%
5 Years
-78.84%
0%
-78.84%
Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Mangalam Drugs and Organics Ltd has not been a consistent performer in the YTD and longer periods
2
Quartile
QTD
-0.22%
2
Quartile
Jun-Sep
9.33%
4
Quartile
Mar-Jun
2.81%
4
Quartile
YTD
-55.53%
4
Quartile
2025
-76.21%
2
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Mangalam Drugs and Organics Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
2
Quartile
QTD
-0.22%
2
Quartile
Jun-Sep
9.33%
4
Quartile
Mar-Jun
2.81%
4
Quartile
YTD
-55.53%
4
Quartile
2025
-76.21%
3
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXRisk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
